Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Coemans

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 7, 2024
A competing risks model to estimate the risk of graft failure and patient death after kidney transplantation using continuous donor-recipient age combinationsMaarten Coemans, Thuong Hien Tran, Bernd Döhler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 8, 2019
Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantationAleksandar Senev, Evelyne Lerut, Vicky Van Sandt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 2021
The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodiesMaarten Coemans, Aleksandar Senev, Elisabet Van Loon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 15, 2018
Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcomeAleksandar Senev, Maarten Coemans, Evelyne Lerut, et al.
Kidney International|March 6, 2021
Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodiesAleksandar Senev, Elisabet Van Loon, Evelyne Lerut, et al.
Journal of the American Society of Nephrology : JASN|July 24, 2021
Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based StudyJasper Callemeyn, Aleksandar Senev, Maarten Coemans, et al.
Kidney International|July 28, 2018
Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015Maarten Coemans, Caner Süsal, Bernd Döhler, et al.
Transplantation|February 25, 2020
Assessing the Complex Causes of Kidney Allograft LossElisabet Van Loon, Aleksandar Senev, Evelyne Lerut, et al.
Clinical Kidney Journal|April 10, 2025
Primary FSGS is not associated with worse kidney outcome compared with other FSGS subtypesDries Deleersnijder, Evert Cleenders, Maarten Coemans, et al.
HLA|June 27, 2024
Sensitive HLA antibody testing and the risk of antibody-mediated rejection and graft failureTim Debyser, Jasper Callemeyn, Maarten Coemans, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 7, 2024
A competing risks model to estimate the risk of graft failure and patient death after kidney transplantation using continuous donor-recipient age combinationsMaarten Coemans, Thuong Hien Tran, Bernd Döhler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 8, 2019
Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantationAleksandar Senev, Evelyne Lerut, Vicky Van Sandt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 2021
The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodiesMaarten Coemans, Aleksandar Senev, Elisabet Van Loon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 15, 2018
Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcomeAleksandar Senev, Maarten Coemans, Evelyne Lerut, et al.
Kidney International|March 6, 2021
Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodiesAleksandar Senev, Elisabet Van Loon, Evelyne Lerut, et al.
Journal of the American Society of Nephrology : JASN|July 24, 2021
Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based StudyJasper Callemeyn, Aleksandar Senev, Maarten Coemans, et al.
Kidney International|July 28, 2018
Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015Maarten Coemans, Caner Süsal, Bernd Döhler, et al.
Transplantation|February 25, 2020
Assessing the Complex Causes of Kidney Allograft LossElisabet Van Loon, Aleksandar Senev, Evelyne Lerut, et al.
Clinical Kidney Journal|April 10, 2025
Primary FSGS is not associated with worse kidney outcome compared with other FSGS subtypesDries Deleersnijder, Evert Cleenders, Maarten Coemans, et al.
HLA|June 27, 2024
Sensitive HLA antibody testing and the risk of antibody-mediated rejection and graft failureTim Debyser, Jasper Callemeyn, Maarten Coemans, et al.
Pageof 4